Cedeodarin

CAS : 31076-39-8

Ref. 3D-GBA07639

Informations sur le produit

• Nom: Cedeodarin
• Synonymes: (2R,3R)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-6-methyl-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-6-methyl-, (2R,3R)-, 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-6-methyl-, (2R-trans)-, 6-Methyldihydroquercetin, Flavanone, 3,3′,4′,5,7-pentahydroxy-6-methyl-

Description

Cedeodarin is a potent inhibitor of the protein Dr5 and has been shown to suppress tumor development in animal models. It may also be used for treatment of cancer due to its ability to inhibit the production of inflammatory cytokines such as TNF-related apoptosis-inducing ligand (TRAIL). Cedeodarin has been shown to have anti-cancer properties by inhibiting the growth of cancer cells and inducing cell death. This compound also inhibits xanthine oxidase, which can lead to decreased levels of uric acid in blood.
Cedeodarin is derived from the Indian plant Cephalotaxus drupacea and has a hydroxyl group at position 5 on the indole ring that acts as a pharmacophore. The presence of this functional group makes cedeodarin an inhibitor of xanthine oxidase, which has been shown to inhibit tumor development in animal models. This compound also inhibits toll-like receptor 4 (TLR

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 318.28 g/mol
• Formule: C₁₆H₁₄O₇
• Degré de pureté: Min. 95%